Physician profile
Jasdeep Dhami
NPI 1770978579
$1,494.52
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $146 · 2021: $139 · 2024: $24.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $308.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $266.17 | 2019-2020 | |
| Edwards Lifesciences Corporation | $139.39 | 2021 | |
| Novo Nordisk INC | $134.09 | 2019-2024 | Rybelsus, Ozempic |
| Teva Pharmaceuticals USA, INC. | $120.31 | 2019 | |
| Merck Sharp & Dohme LLC | $66.69 | 2019 | |
| Lilly USA, LLC | $62.79 | 2019-2020 | |
| Pfizer INC. | $62.70 | 2019-2020 | |
| Amarin Pharma, INC. | $58.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $50.82 | 2019 | |
| Amgen INC. | $41.90 | 2019 | |
| Smith+Nephew, INC. | $30.26 | 2019 | |
| Sanofi Pasteur INC. | $25.04 | 2020 | |
| Sanofi-Aventis U.S. LLC | $24.61 | 2019 | |
| Shire North American Group INC | $22.02 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $19.23 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.51 | 2019 | |
| Hikma Pharmaceuticals USA | $17.48 | 2019 | |
| Glaxosmithkline, LLC. | $15.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasdeep Dhami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.